Javascript is not enabled on this browser. This site will not work properly without Javascript.
|
1
|
(2011) CST Curation Set: 12712; Year: ; Biosample: Jurkat; Disease: T cell leukemia; Treatment: calyculin & pervanadate; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)XP(phosphorylation)
Curated Info
|
|
2
|
(2011) CST Curation Set: 11985; Year: 2011; Biosample: Jurkat; Disease: T cell leukemia; Treatment: calyculin & pervanadate; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)XP(phosphorylation)
Curated Info
|
|
3
|
(2010) CST Curation Set: 9250; Year: 2010; Biosample: Jurkat; Disease: T cell leukemia; Treatment: pervanadate & calyculin; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)XP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-(Ser) 14-3-3 Binding Motif Antibody Cat#: 9601
Curated Info
|
|
4
|
(2009) CST Curation Set: 8039; Year: 2009; Biosample: Jurkat; Disease: T cell leukemia; Treatment: pervanadate & calyculin; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)XP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-(Ser) 14-3-3 Binding Motif (4E2) Mouse mAb Cat#: 9606
Curated Info
|
|
5
|
Thingholm TE, et al. (2008) TiO2-Based Phosphoproteomic Analysis of the Plasma Membrane and the Effects of Phosphatase Inhibitor Treatment. J Proteome Res 7, 3304-3313
18578522
Curated Info
|
